Clinically important interaction between metoprolol and propafenone
Language English Country Canada Media print
Document type Case Reports, Journal Article
PubMed
23585605
PubMed Central
PMC3625083
PII: 59/4/373
Knihovny.cz E-resources
- MeSH
- Anti-Arrhythmia Agents pharmacology therapeutic use MeSH
- Antihypertensive Agents therapeutic use MeSH
- Cytochrome P-450 CYP2D6 genetics metabolism MeSH
- Diuretics therapeutic use MeSH
- Dyspnea chemically induced MeSH
- Atrial Fibrillation prevention & control MeSH
- Hypertension drug therapy MeSH
- Drug Interactions MeSH
- Humans MeSH
- Metoprolol analogs & derivatives blood pharmacology therapeutic use MeSH
- Propafenone pharmacology therapeutic use MeSH
- Medication Reconciliation MeSH
- Aged MeSH
- Fatigue chemically induced MeSH
- Check Tag
- Humans MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Names of Substances
- alpha-hydroxymetoprolol MeSH Browser
- Anti-Arrhythmia Agents MeSH
- Antihypertensive Agents MeSH
- Cytochrome P-450 CYP2D6 MeSH
- Diuretics MeSH
- Metoprolol MeSH
- Propafenone MeSH
See more in PubMed
Kroemer HK, Fischer C, Meese CO, Eichelbaum M. Enantiomer/enantiomer interaction of (S)- and (R)-propafenone for cytochrome P450IID6-catalyzed 5-hydroxylation: in vitro evaluation of the mechanism. Mol Pharmacol. 1991;40(1):135–42. PubMed
Otton SV, Inaba T, Kalow W. Competitive inhibition of sparteine oxidation in human liver by beta-adrenoceptor antagonists and other cardiovascular drugs. Life Sci. 1984;34(1):73–80. PubMed
Frank D, Jaehde U, Fuhr U. Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping. Eur J Clin Pharmacol. 2007;63(4):321–33. Epub 2007 Feb 2. PubMed
Abrahamsson B, Lücker P, Olofsson B, Regårdh CG, Sandberg A, Wieselgren I, et al. The relationship between metoprolol plasma concentration and beta 1-blockade in healthy subjects: a study on conventional metoprolol and metoprolol CR/ZOK formulations. J Clin Pharmacol. 1990;30(2 Suppl):S46–54. PubMed
Regårdh CG, Johnsson G. Clinical pharmacokinetics of metoprolol. Clin Pharmacokinet. 1980;5(6):557–69. PubMed
Wagner F, Kalusche D, Trenk D, Jähnchen E, Roskamm H. Drug interaction between propafenone and metoprolol. Br J Clin Pharmac. 1987;24(2):213–20. PubMed PMC
Zanger UM, Raimundo S, Eichelbaum M. Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch Pharmacol. 2004;369(1):23–37. Epub 2003 Nov 15. PubMed
Perinova I, Duricova J, Brozmanova H, Kacirova I, Grundmann M. Determination of metoprolol and its metabolite α-hydroxymetabolite in serum by HPLC method with fluorescence detection [article in Czech] Ces Farm. 2008;57(6):254–9.
Jonkers RE, Koopmans RP, Portier EJ, van Boxtel CJ. Debrisoquine phenotype and the pharmacokinetics and beta-2 receptor pharmacodynamics of metoprolol and its enantiomers. J Pharmacol Exp Ther. 1991;256(3):959–66. PubMed
Labbé L, O’Hara G, Lefebvre M, Lessard E, Gilbert M, Adedoyin A, et al. Pharmacokinetic and pharmacodynamic interaction between mexiletine and propafenone in human beings. Clin Pharmacol Ther. 2000;67(1):44–57. PubMed
Fukumoto K, Kobayashi T, Tachibana K, Kato R, Kazuhiko T, Komamura K. Effect of amiodarone on the serum concentration/dose ratio of metoprolol in patients with cardiac arrhythmia. Drug Metab Pharmacokinet. 2006;21(6):501–5. PubMed
Hamelin BA, Bouayad A, Méthot J, Jobin J, Desgagnés P, Poirier P, et al. Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity. Clin Pharmacol Ther. 2000;67(5):466–77. PubMed
Walley T, Pirmohamed M, Proudlove C, Maxwell D. Interaction of metoprolol and fluoxetine. Lancet. 1993;341(8850):967–8. PubMed
Onalan O, Cumurcu BE, Bekar L. Complete atrioventricular block associated with concomitant use of metoprolol and paroxetine. Mayo Clin Proc. 2008;83(5):595–99. doi: 10.4065/83.5.595. PubMed DOI
The Human Cytochrome P450 (CYP) Allele Nomenclature Database [website] CYP2D6 allele nomenclature. Stockholm, Sweden: The Human Cytochrome P450 (CYP) Allele Nomenclature Database; 2012. Available from: www.cypalleles.ki.se/cyp2d6.htm. Accessed 2013 Jan 11.
Sachse C, Brockmöller J, Bauer S, Roots I. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet. 1997;60:284–95. PubMed PMC
Lee JT, Kroemer HK, Silberstein DJ, Funck-Bretano C, Lineberry MD, Wood AJ, et al. The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone. N Engl J Med. 1990;322(25):1764–8. PubMed